Post-streptococcal glomerulonephritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


 
The incidence of [[post-streptococcal glomerulonephritis]] is approximately 9.5 to 28.5 per 100,000 individuals worldwide.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.<ref name="pmid16253886">{{cite journal |vauthors=Carapetis JR, Steer AC, Mulholland EK, Weber M |title=The global burden of group A streptococcal diseases |journal=Lancet Infect Dis |volume=5 |issue=11 |pages=685–94 |date=November 2005 |pmid=16253886 |doi=10.1016/S1473-3099(05)70267-X |url=}}</ref>
The incidence of [[post-streptococcal glomerulonephritis]] is approximately 9.5 to 28.5 per 100,000 individuals worldwide.<ref name="pmid16253886">{{cite journal |vauthors=Carapetis JR, Steer AC, Mulholland EK, Weber M |title=The global burden of group A streptococcal diseases |journal=Lancet Infect Dis |volume=5 |issue=11 |pages=685–94 |date=November 2005 |pmid=16253886 |doi=10.1016/S1473-3099(05)70267-X |url=}}</ref>


===Case-fatality rate===
===Case-fatality rate===

Revision as of 19:46, 14 June 2018

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis epidemiology and demographics

CDC on Post-streptococcal glomerulonephritis epidemiology and demographics

Post-streptococcal glomerulonephritis epidemiology and demographics in the news

Blogs on Post-streptococcal glomerulonephritis epidemiology and demographics

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.

Epidemiology and Demographics

Incidence

The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.[1]

Case-fatality rate

The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey.[2]

Age

  • The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years.
  • It commonly affects children with age between 5 to 12 years.

Race

There is no racial predilection to post-streptococcal glomerulonephritis.

Gender

Mens are more commonly affected by post-streptococcal glomerulonephritis than women.

Region

The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.[3]

References

  1. Carapetis JR, Steer AC, Mulholland EK, Weber M (November 2005). "The global burden of group A streptococcal diseases". Lancet Infect Dis. 5 (11): 685–94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.
  2. Jackson SJ, Steer AC, Campbell H (January 2011). "Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis". Trop. Med. Int. Health. 16 (1): 2–11. doi:10.1111/j.1365-3156.2010.02670.x. PMID 21371205.
  3. Rodriguez-Iturbe B, Musser JM (October 2008). "The current state of poststreptococcal glomerulonephritis". J. Am. Soc. Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.

Template:WH